News
Hosted on MSN12mon
Adding chemotherapy to hormone therapy helps control locally advanced prostate cancer, finds studyFor patients with locally advanced prostate cancer, combined treatment with chemotherapy and hormonal therapy offers extended control of prostate-specific antigen (PSA) levels, compared to ...
Hormone therapy for prostate cancer is also being tested in combination with other therapies, like radiation and chemotherapy. One recent study looked at men with locally advanced prostate cancer ...
Aside from that intensely intimate storyline, what we noted was the absence of Craig Parkinson's Norman Potting. It was ...
Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal cancers.
Now, they can receive treatment locally at Providence Cancer Center ... Alaskans facing advanced prostate cancer have access to a new option, a new approach, and a new hope closer to home.
The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for gastrointestinal and genitourinary cancers such as prostate-specific membrane antigen ...
can suppress testosterone to castrate levels in men with locally advanced or metastatic prostate cancer. This novel method of androgen deprivation might be preferable to administration of oral ...
Baseline characteristics were similar between the degarelix 240/80 mg and leuprolide 7.5 mg groups, with approximately half of patients having locally advanced or metastatic disease and a Gleason ...
Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...
A 61-year-old patient, initially presenting with urinary complaints, has undergone Stereotactic Body Radiation Therapy (SBRT) for prostate cancer at KMC Hospital Attavar Oncology Centre (KMCHAOC) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results